Ali Tafreshi discusses Oku Digital Health, launched from Topcon to link eye care with primary care, and the barriers ahead.
At EURETINA 2026, David Steel reviewed registry evidence on gas and silicone oil tamponades for retinal detachment repair and ...
The double vision can be a symptom of tumors affecting the eye muscles or nerves; the changes in eye appearance, ie, a sunken or bulging eye might be a sign of a tumor in the orbit.Horner's syndrome ...
Host Deborah Ristvedt, DO, welcomes Dr. Mathews to discuss the relationships, passions, and intentional choices that have shaped her career as a cornea, cataract, and refractive surgeon, dry eye ...
At EURETINA 2026, Roger Goldberg, MD, MBA, explains why EYP-1901 missed LUGANO's primary endpoint despite matched anatomy, clean safety and a 42% cut in treatment burden. EyePoint's sustained-release ...
Cataract original papers on intracameral antibiotics and IOL power, a guideline-based case symposium, and ocular surface ...
At EURETINA 2026, Arshad Khanani, MD, FASRS, reviews sura-vec, 4D-150 and ixo-vec, 3 nAMD gene therapies in phase 3 with ...
The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared equally among Karl Deisseroth, MD, PhD, of the Howard Hugh ...
João Pedro Marques, MD, MSc, PhD, FEBOphth, an ophthalmic genetics and retina specialist from Coimbra, Portugal, spoke at the ...
The American Academy of Ophthalmology (AAO) returns to New Orleans from October 9-12 for AAO 2026, with more than 20,000 ...
At EURETINA 2026, Elon van Dijk, MD, PhD, FEBOphth, reviewed trial evidence favouring half-dose PDT over micropulse laser and ...
Our FORCE experience with FYB-201 has been very encouraging. The original FORCE study provided multicentre real-world evidence across retinal vascular diseases, and our recent Middle Eastern extension ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results